European Partnership for Fostering a European Research Area for Health (ERA4Health)
The European Partnership for Fostering a European Research Area for Health (ERA4Health) is a partnership bringing together 37 entities from 24 countries. It aims to support transnational medical research in prevention, diagnosis, treatment, capacity building, and responsible research and innovation (RRI).
In 2024, three calls for proposals were published:
- NutriBrain, focusing on modulation of brain ageing through nutrition and healthy lifestyle (closed)
- NANOTECMEC, focusing on nano and advanced technologies for disease prevention, diagnosis, and therapy (closed)
- EffecTrial, focusing on pragmatic comparative effectiveness studies in non-communicable diseases (open)
European Partnership for Fostering a European Research Area for Health (ERA4Health)
Directorate-General for Research and Innovation (DG RTD)
ERA4Health is a partnership under Horizon Europe covering 2022-2028.
The total indicative budget for the duration of ERA4Health is EUR 110 million.
Depending on the specific call for proposals
Grants
Project partners from countries participating in the call for proposals
ERA4Health is being implemented in two phases:
- Phase 1 (ongoing): Joint calls focused on nutrition and lifestyle-related diseases, cardiovascular diseases and nanomedicine are implemented. Overall, four calls are expected to be launched during this phase.
- Phase 2: Additional joint calls focused on multinational investigator-initiated clinical studies for other priority areas are expected to be launched in accordance with the decision of the Health Programme Committee and the European Commission. Updates on this matter will follow as soon as possible.
Depending on the funding organisations participating in the specific call for proposals. Generally, only transnational projects are funded.
Depending on the specific call for proposals. For EffecTrial, the initial project duration is 48 months.
Currently unavailable
All stages
Unknown
EffecTrial: Overview here
EffecTrial: Open (submission of pre-proposals closes on 28 January 2025)